Intercell Supports The Japanese Encephalitis Vaccination Recommendations Of CDC’s Advisory Committee On Immunization Practices

Intercell AG (VSE: ICLL) announced that the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted to update its previous recommendations and include IXIARO, a new Japanese Encephalitis (JE) vaccine for travelers to countries in Asia where the disease is endemic, as well as Americans living in such high-risk areas.

More: continued here

Filed under: Immune System / Vaccines on June 27th, 2009